Literature DB >> 18559852

Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Dean Ornish1, Mark Jesus M Magbanua, Gerdi Weidner, Vivian Weinberg, Colleen Kemp, Christopher Green, Michael D Mattie, Ruth Marlin, Jeff Simko, Katsuto Shinohara, Christopher M Haqq, Peter R Carroll.   

Abstract

Epidemiological and prospective studies indicate that comprehensive lifestyle changes may modify the progression of prostate cancer. However, the molecular mechanisms by which improvements in diet and lifestyle might affect the prostate microenvironment are poorly understood. We conducted a pilot study to examine changes in prostate gene expression in a unique population of men with low-risk prostate cancer who declined immediate surgery, hormonal therapy, or radiation and participated in an intensive nutrition and lifestyle intervention while undergoing careful surveillance for tumor progression. Consistent with previous studies, significant improvements in weight, abdominal obesity, blood pressure, and lipid profile were observed (all P < 0.05), and surveillance of low-risk patients was safe. Gene expression profiles were obtained from 30 participants, pairing RNA samples from control prostate needle biopsy taken before intervention to RNA from the same patient's 3-month postintervention biopsy. Quantitative real-time PCR was used to validate array observations for selected transcripts. Two-class paired analysis of global gene expression using significance analysis of microarrays detected 48 up-regulated and 453 down-regulated transcripts after the intervention. Pathway analysis identified significant modulation of biological processes that have critical roles in tumorigenesis, including protein metabolism and modification, intracellular protein traffic, and protein phosphorylation (all P < 0.05). Intensive nutrition and lifestyle changes may modulate gene expression in the prostate. Understanding the prostate molecular response to comprehensive lifestyle changes may strengthen efforts to develop effective prevention and treatment. Larger clinical trials are warranted to confirm the results of this pilot study.

Entities:  

Mesh:

Year:  2008        PMID: 18559852      PMCID: PMC2430265          DOI: 10.1073/pnas.0803080105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Intensive lifestyle changes for reversal of coronary heart disease.

Authors:  D Ornish; L W Scherwitz; J H Billings; S E Brown; K L Gould; T A Merritt; S Sparler; W T Armstrong; T A Ports; R L Kirkeeide; C Hogeboom; R J Brand
Journal:  JAMA       Date:  1998-12-16       Impact factor: 56.272

2.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

3.  The gene expression signatures of melanoma progression.

Authors:  Christopher Haqq; Mehdi Nosrati; Daniel Sudilovsky; Julia Crothers; Daniel Khodabakhsh; Brian L Pulliam; Scot Federman; James R Miller; Robert E Allen; Mark I Singer; Stanley P L Leong; Britt-Marie Ljung; Richard W Sagebiel; Mohammed Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

4.  Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States.

Authors:  H Yu; R E Harris; Y T Gao; R Gao; E L Wynder
Journal:  Int J Epidemiol       Date:  1991-03       Impact factor: 7.196

5.  The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan.

Authors:  S Egawa; S Soh; M Ohori; T Uchida; K Gohji; A Fujii; S Kuwao; K Koshiba
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

6.  Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA.

Authors:  P J Van Cangh; P De Nayer; L De Vischer; P Sauvage; B Tombal; F Lorge; F X Wese; R Opsomer
Journal:  Urology       Date:  1996-12       Impact factor: 2.649

7.  Use of a cDNA microarray to analyse gene expression patterns in human cancer.

Authors:  J DeRisi; L Penland; P O Brown; M L Bittner; P S Meltzer; M Ray; Y Chen; Y A Su; J M Trent
Journal:  Nat Genet       Date:  1996-12       Impact factor: 38.330

8.  Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.

Authors:  P J Van Cangh; P De Nayer; P Sauvage; B Tombal; M Elsen; F Lorge; R Opsomer; F X Wese
Journal:  Prostate Suppl       Date:  1996

9.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy.

Authors:  Z Li; W J Aronson; J R Arteaga; K Hong; G Thames; S M Henning; W Liu; R Elashoff; J M Ashley; D Heber
Journal:  Eur J Clin Nutr       Date:  2007-03-28       Impact factor: 4.016

View more
  77 in total

1.  Introduction to section on integrative oncology.

Authors:  Kathleen M Wesa; Barrie R Cassileth
Journal:  Curr Treat Options Oncol       Date:  2010-12

2.  Flavonoids and isoflavonoids: from plant biology to agriculture and neuroscience.

Authors:  Richard A Dixon; Giulio M Pasinetti
Journal:  Plant Physiol       Date:  2010-10       Impact factor: 8.340

3.  Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication.

Authors:  Ramy A Abdelsalam; Ibrahim Khalifeh; Alan Box; Maria Kalantarian; Sunita Ghosh; Hatem Abou-Ouf; Tamara Lotfi; Mohammed Shahait; Nallasivam Palanisamy; Tarek A Bismar
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-30       Impact factor: 4.553

Review 4.  Behavior matters.

Authors:  Edwin B Fisher; Marian L Fitzgibbon; Russell E Glasgow; Debra Haire-Joshu; Laura L Hayman; Robert M Kaplan; Marilyn S Nanney; Judith K Ockene
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

5.  2012 integrative healthcare symposium: treating the pain of lyme disease and adopting lifestyle change as therapy.

Authors:  Walter Alexander
Journal:  P T       Date:  2012-04

6.  Social regulation of human gene expression: mechanisms and implications for public health.

Authors:  Steven W Cole
Journal:  Am J Public Health       Date:  2013-08-08       Impact factor: 9.308

7.  GPRC6A regulates prostate cancer progression.

Authors:  Min Pi; L Darryl Quarles
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

Review 8.  Enhancing active surveillance of prostate cancer: the potential of exercise medicine.

Authors:  Daniel A Galvão; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Renea Taylor; Gail P Risbridger; Mark Frydenberg; Michelle Hill; Suzanne K Chambers; Phillip Stricker; Tom Shannon; Dickon Hayne; Eva Zopf; Robert U Newton
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

9.  Regular recreational physical activity and risk of hematologic malignancies: results from the prospective VITamins And lifestyle (VITAL) study.

Authors:  R B Walter; S A Buckley; E White
Journal:  Ann Oncol       Date:  2012-12-17       Impact factor: 32.976

10.  How the mid-Victorians worked, ate and died.

Authors:  Paul Clayton; Judith Rowbotham
Journal:  Int J Environ Res Public Health       Date:  2009-03-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.